**Question:** DOC for Chlamydia trachomatis in pregnancy

**Core Concept:** Chlamydia trachomatis (CT) is a common sexually transmitted infection (STI) that can lead to severe complications in pregnant women and their neonates if left untreated.

**Why the Correct Answer is Right:** The correct answer, azithromycin (A), is a macrolide antibiotic that is effective against CT infections. Azithromycin is well-tolerated, has a low risk of drug interactions, and provides a single-dose treatment regimen, which is beneficial for pregnant women as it reduces the risk of adverse drug reactions and minimizes the potential impact on the developing fetus.

**Why Each Wrong Option is Incorrect:**

A. Ceftriaxone (C) is a third-generation cephalosporin antibiotic, which is not recommended for the treatment of CT infections in pregnancy due to its potential for causing fetal exposure and the risk of premature rupture of membranes (PROM) and neonatal conjunctivitis.

B. Trimethoprim-sulfamethoxazole (TS) is a combination antibiotic used for treating CT infections, but it is not the first-choice treatment option in pregnancy due to its potential to cause fetal erythroblastosis (anemia) and premature rupture of membranes (PROM).

D. Nitroimidazole derivatives like metronidazole (M) are not the first choice for treating CT infections in pregnancy due to their potential to cause birth defects, particularly neural tube defects, and are contraindicated in pregnant women.

**Clinical Pearl:** In pregnancy, the first-line treatment for CT infections should be a macrolide antibiotic like azithromycin, which reduces the risk of adverse fetal outcomes and provides a single-dose regimen for simplicity and patient compliance. Close follow-up after treatment is essential to monitor for potential complications in both the mother and the baby.